NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
External Expert Profile
O. A. N. Husain
Latest Publications
Are Recommendations for HTA of Gene Therapies Being Achieved?
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
Real-World Evidence: Current Best Practice for Reimbursement Decision-Making
Delivering the Triple Win: A Value-Based Approach to Pricing
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
Read more
© NCI/Unsplash
